ELIV5

ELIV5 Therapeutics aims to develop a new class of antifungal drugs that target a critical step in fungal metabolism required for pathogen survival and virulence.   ELIV5 Team: Choukri Ben Mamoun

Read More

Bow Therapeutics

Bow Therapeutics is developing isolation of human monoclonal antibodies against Chikungunya Virus Glycoprotein using Single B-cell sorting Technology.   Bow Therapeutics Team: George Georgiev Jose Quiroz    

Read More

Unicrobe

We will provide bacterial genome editing services using CRISPR-Cas technologies for academic and industrial customers interested in improving human health and developing bacterial technologies. Team: Wenyan Jiang – CEO, CSO Yuchen Qi – Business Development

Read More

MouSensor, Inc.

MouSensors provide the first genetic platform for smell pharmacology to assist humans in scent detection tasks such as non-invasive cancer diagnosis, Tuberculosis identification, explosives detection etc. Team: Paul Feinstein, PhD. – Co-founder Charlotte D’Hulst, PhD. – Co-founder

Read More

Ionica Sciences

Ionica Sciences is developing a spectroscopy-based diagnostic platform capable of targeting myriad infectious diseases, with Lyme disease serving as our initial focus and test case. Team: Omar Green – CEO, Founder Joel Tabb – President, Co-Founder

Read More

Lucida Pathology

A decision support system for automated analysis and diagnosis of histopathology biopsies comprising a physical scanning platform, algorithms, and software. Lucida Pathology Team: Amire Handzel

Read More

Gentroma

A portable DNA sequencer that can make finding out information about one’s genetic ancestry, disease risk, and other factors available to the masses, cost-effectively. Team: Krista Fretes, CEO Parth Shah, CTO

Read More

Avalia Immunotherapies

Avalia Immunotherapies – A synthetic immunotherapy platform for self-adjuvanting vaccines, with a unique mode of action, aiming to improve clinical outcomes for cancer, allergy and infectious disease. Avalia Immunotherapies Team: Shivali Gulab, CEO    

Read More